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ABSTRACT
While DNA methylation is usually thought to be symmetrical across both alleles, there are some notable
exceptions. Genomic imprinting and X chromosome inactivation are two well-studied sources of
allele-speciﬁc methylation (ASM), but recent research has indicated a more complex pattern in which
genotypic variation can be associated with allelically-skewed DNA methylation in cis. Given the known
heterogeneity of DNA methylation across tissues and cell types we explored inter- and intra-individual
variation in ASM across several regions of the human brain and whole blood from multiple individuals.
Consistent with previous studies, we ﬁnd widespread ASM with > 4% of the »220,000 loci interrogated
showing evidence of allelically-skewed DNA methylation. We identify ASM ﬂanking known imprinted
regions, and show that ASM sites are enriched in DNase I hypersensitivity sites and often located in an
extended genomic context of intermediate DNA methylation. We also detect examples of genotype-
driven ASM, some of which are tissue-speciﬁc. These ﬁndings contribute to our understanding of the
nature of differential DNA methylation across tissues and have important implications for genetic studies
of complex disease. As a resource to the community, ASM patterns across each of the tissues studied are
available in a searchable online database: http://epigenetics.essex.ac.uk/ASMBrainBlood.
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Introduction
DNA methylation is the most widely studied and stable epige-
netic mark across the mammalian genome, playing a key role
in the developmental regulation of gene expression. DNA
methylation is generally symmetrical across both alleles,
although exceptions characterized by allelic asymmetry include
differentially methylated regions (DMRs) regulating the mono-
allelic expression of genes associated with X chromosome inac-
tivation in females and genomic imprinting.1-5 Recently, it has
been shown that the allelic-skewing of DNA methylation can
also be driven by DNA sequence variation, with methylation
quantitative trait loci (meQTLs) predominantly acting in
cis.6-11 ASM can be regarded as a special case of intermediate
DNA methylation (IM), which has been found to occur in
regions spanning a large portion of the human genome. It has
been estimated that ASM contributes up to 18% of IM in the
human genome.12
DNA methylation patterns are highly dynamic during nor-
mal development and cellular differentiation13-16 and tissue-spe-
ciﬁc patterns of DNA methylation have been widely studied in
humans.17-20 In complex tissues such as the brain, for example,
DNA methylation differentiates between functionally distinct
regions21,22 and cell types.16,23-26 Patterns of IM can also be tis-
sue-speciﬁc,12 with growing evidence for the widespread preva-
lence of tissue-speciﬁc ASM.27,28 In mouse, for example, it has
been reported that 28% of imprinted genes are monoallelically
expressed in a single tissue type, often the brain or extra-embry-
onic tissue.29 Examples of tissue-speciﬁcally imprinted genes
include KCNQ1, which becomes biallelically expressed in
embryonic heart development,30 GNAS, which is maternally
expressed in a wide-range of tissues including the anterior pitui-
tary, thyroid and ovaries but biallelically expressed in others,
such as bone and visceral adipose tissue,31,32 and GRB10, which
is maternally expressed in most peripheral tissues but paternally
expressed in the brain.29,33Genetic inﬂuences on DNAmethyla-
tion can also be tissue-speciﬁc, with meQTLs determining allelic
patterns of methylation in cis in certain tissues or cell types.11,34
Increasing evidence supports a role for inter-individual vari-
ation in DNA methylation in the etiology and pathogenesis
associated with a diverse range of complex disease pheno-
types.35 Allelic differences in DNA methylation may be particu-
larly important in this regard, acting as endophenotypes of
genetic variation or additional epi-allelic layers mediating the
functional consequences of genotypic variation.36,37 Teasing
apart genetic and non-genetic effects in a tissue- and cell type-
speciﬁc manner will be a crucial step in understanding the asso-
ciation between non-coding genetic variation, DNA methyla-
tion, and complex disease.
To investigate the role of tissue-speciﬁc variation of ASM in
the human brain and its relation to allelic biases in whole blood,
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we examined ASM across multiple brain regions and matched
blood samples collected from multiple donors. Our data shows
that although a large proportion of ASM is conserved across
tissues, there are speciﬁc differences in the extent and distribu-
tion of ASM sites between regions of the brain and whole
blood. Genome browser tracks displaying ASM signals as well
as an online tool plotting ASM for sites of interest are available
for download from a searchable database (http://epigenetics.
essex.ac.uk/ASMBrainBlood).
Results
DNA methylation is allelically-skewed at speciﬁc locations
across the genome
The majority of the genome is not characterized by notable
allelic biases in DNA methylation in any of the tissues assessed
in this study. The array-wide average of ASM score (in absolute
values) is consistently low (mean D 0.025, range D 0.023 to
0.030) (Fig. S1A, Fig. S1B and Table S1). As expected, there is,
however, evidence for allelically-biased DNA methylation at a
notable number of speciﬁc genomic regions; in total 9,311
(4.22%) of the 220,449 informative SNPs in our assay show evi-
dence for allelic-skewing of DNA methylation, deﬁned by an
absolute ASM score  0.10 in at least one tissue and individual.
The percentage of amplicons characterized by an ASM score
 0.10 in each of the 21 proﬁled samples is given in Table S2.
The top-ranked loci showing evidence for allelically-skewed
DNA methylation in whole blood, cerebellum, and cortex
(BA9), and cerebellum are listed in Tables 1–3. Genome
Browser tracks and an online ASM database are available from
our laboratory website (http://epigenetics.essex.ac.uk/ASM
BrainBlood).
Patterns of ASM in whole blood overlap with those
identiﬁed in a previous study
In a previous study we characterized allelically-skewed DNA
methylation in whole blood derived from 5 monozygotic twin
pairs.7 There is a highly signiﬁcant correlation between absolute
ASM scores across all probes informative in both data sets
(n D 129,559, r D 0.21, P < 1.0 £ 10¡50, Fig. S2), even though
the majority of the probes do not exhibit ASM. Of the 2,704
ASM loci identiﬁed in Schalkwyk et al., 1,717 (63.50%) are
informative in the current study, with a highly signiﬁcant
cross-study correlation of ASM scores at these probes (r D
0.52, P < 1.0 £ 10¡50). Likewise, there is a highly signiﬁcant
correlation between ASM scores across the two studies at sites
showing allelically-skewed DNA methylation in blood in the
current study which were also informative in our previous
study (r D 0.38, P D 3.0 £ 10-28). Of the 15 top-ranked blood
ASM sites identiﬁed in our current study (Table 1), 7 of the 9
sites (78%) also informative in our previous study of ASM in
blood7 were characterized by an absolute ASM score  0.10 in
both analyses. These data conﬁrm the validity of the MSNP
approach for identifying allelically-skewed DNA methylation,
reinforcing our previous conclusions about the extent of ASM
in whole blood.7
The extent and distribution of ASM differs across tissues
The average proportion of informative sites characterized by
allelically-skewed DNA methylation (absolute ASM score
 0.10) in each of the 8 tissues proﬁled was examined (Fig. 1A).
Table 4 lists the top-ranked consistently allelically-skewed
probes across cerebellum, whole blood, and cortex (BA9), with
speciﬁc examples shown in Figure 2A and Figure 2B. Allelically-
skewed DNA methylation appears to be consistently less preva-
lent in cortical regions (informative probes with ASM score
 0.10D 0.54%) compared to the cerebellum (1.14%) and whole
blood (0.84%). The elevated level of allelically-skewed DNA
methylation in the cerebellum and whole blood relative to cortex
is more pronounced at more extreme ASM score thresholds
(i.e., ASM score  0.20, cortexD 0.003%, cerebellum D 0.019%,
whole bloodD 0.013%) (Fig. S1C, Fig. S1D and Fig. S3). Of note,
there is little variation in the prevalence and distribution of ASM
scores between different regions of the cortex (average correla-
tion between 2 cortical areas D 0.52, Fig. 1B and Fig. S4). We
therefore selected one representative cortical region (BA9) for
inclusion in subsequent analyses. In contrast, we ﬁndmore strik-
ing differences between cortex, cerebellum and whole blood
samples with inter-tissue correlations ranging from r D 0.42 to
Table 1. Top 15 ASM sites in whole blood, ASM score averaged across individuals.
Rank SNP ID Location Associated gene(s) Schalkwyk et al. (2010) Blood ASM score Cerebellum ASM score BA9 ASM score
1 SNP_A-2180729 (rs10276966) 7p15.2 HIBADH, EVX1b 0.29 0.25 0.01 0.03
2 SNP_A-8438077 (rs585451) 15q21.2 ATP8B4, DTWD1 NA 0.25 0.01 0.03
3 SNP_A-1841543 (rs10234308) 7p15.3 MGC87042 0.34 0.23 0.25 0.23
4 SNP_A-1946136 (rs927000) 20q13.12 STK4 NA 0.23 0.04 0.01
5 SNP_A-8450837 (rs4404067) 16q12.2 SLC6A2, LPCAT2 0.28 0.22 0.05 0.04
6 SNP_A-4279002 (rs335554) 1q41 CENPF, KCNK2 NA 0.22 0.08 0.09
7 SNP_A-8450539 (rs10916799) 1p36.12 CAMK2N1, LOC339505 0.18 0.22 0.11 0.15
8 SNP_A-8633222 (rs13165930) 5q33.3 CCNJL NA 0.22 0.02 0.12
9 SNP_A-8472169 (rs11193683) 10q23.1 NRG3 0.01 0.22 0.09 0.07
10 SNP_A-2071005 (rs4687210) 3q28 UTS2D NA 0.22 0.16 0.17
11 SNP_A-2185394 (rs852454) 7p22.1 RNF216 0.06 0.22 0.11 0.11
12 SNP_A-8702215 (rs12978286) 19p13.11 FCHO1, MAP1S 0.19 0.22 0.00 0.07
13 SNP_A-1807006 (rs10481354) 8p23.3 CLN8, DLGAP2a 0.22 0.22 0.00 0.05
14 SNP_A-8326632 (rs1542180) 2q31.1 HOXD3, HOXD4 NA 0.21 0.24 0.19
15 SNP_A-2008150 (rs869108) 11p15.1 OTOG, MYOD1, USH1C 0.22 0.21 0.16 0.07
a Known imprinted gene
b Suspected imprinted gene
2 S. J. MARZI ET AL.
D
ow
nl
oa
de
d 
by
 [1
93
.61
.13
.44
] a
t 0
5:4
9 0
2 F
eb
ru
ary
 20
16
 
0.48 (Figs. 1C-E). Table 5 lists the probes showing the highest
level of variation in ASM scores across tissues with speciﬁc
examples shown in Figure 3A and Figure 3B. We used clonal
bisulﬁte sequencing to validate tissue-speciﬁc ASM identiﬁed by
the MSNP method in these 2 regions (Fig. 3C and Fig. 3D), con-
ﬁrming the patterns observed in our array data for both loci.
Informative MSNP probes within DNase I hypersensitive
regions are characterized by elevated ASM scores
Enrichment analyses were performed using a Kruskal-Wallis
rank-sum test for ASM rank differences between the annotated
genic regions (see Materials and Methods). We observed a dif-
ferential distribution of ASM scores across annotated genic
regions (i.e., coding, 50UTR, intergenic, intron, promoter,
30UTR) in cortex (BA9) (P D 1.29 £10¡15), cerebellum
(P D 3.98 £10¡14), whole blood (P D 2.06 £10¡12), and the
cross-tissue analysis (P D 2.12 £10¡26). Post-hoc tests identi-
ﬁed these differences to be primarily driven by an enrichment
of high ASM scores in promoter regions (Fig. S5). We used
data from ENCODE38 to assess whether ASM is enriched in
regions associated with DNase I hypersensitive (DHS) sites
identiﬁed in multiple tissues including frontal cortex and cere-
bellum, as well as CD14C monocytes and na€ıve B cells (as a
proxy for blood). We compared the ASM score ranks for
informative probes between regions deﬁned by the presence or
absence of DHS sites using a Wilcoxon rank-sum test (see
Materials and Methods). DHS peaks across all tissues are
enriched for higher ASM scores identiﬁed in cortex (BA9), cer-
ebellum, and whole blood (Table S3 and Fig. S6). Of note, the
most striking enrichment is found for cerebellum ASM scores
in regions characterized by cerebellum DHS peaks in ENCODE
(P D 3.51 £ 10¡220).
Inter-individual variation in ASM
We next examined inter-individual differences in ASM score at
speciﬁc loci, deﬁning probes with a large range of ASM scores
across the 3 individuals as being characterized by “variable
ASM.” Differentially methylated regions (DMRs) associated
with genomic imprinting, for example, are characterized by
parental-origin-speciﬁc ASM and are expected to show consis-
tently large ASM scores that exhibit allelic-ﬂipping, resulting
from genotype-independent ASM. Genotype-driven ASM, in
contrast, is likely to be exempliﬁed by consistent allelic biases
in DNA methylation across individuals, and is generally not
variable between individuals of the same genotype. Fig. S7
shows the correlation in ASM scores across the 3 individuals
proﬁled by MSNP, with tissue-speciﬁc correlations given in
Table S4. As expected, the individuals were more highly
Table 2. Top 15 ASM sites in cerebellum, ASM score averaged across individuals.
Rank SNP ID Location Associated gene(s) Cerebellum ASM score Blood ASM score BA9 ASM score
1 SNP_A-4255628 (rs959246) 18q12.3 SLC14A2, SETBP1 0.30 0.03 0.05
2 SNP_A-8696273 (rs1003533) 5q31.1 C5orf56 0.29 0.16 0.07
3 SNP_A-1820553 (rs7959070) 12q22 CLLU1OS, BTG1 0.26 0.03 0.05
4 SNP_A-1841543 (rs10234308) 7p15.3 MGC87042 0.25 0.23 0.23
5 SNP_A-2002282 (rs12246813) 10q22.1 COL13A1, C10orf35 0.24 0.10 0.10
6 SNP_A-8625237 (rs12493005) 3q26.32 TBL1XR1 0.24 0.20 0.24
7 SNP_A-8326632 (rs1542180) 2q31.1 HOXD3, HOXD4 0.24 0.21 0.19
8 SNP_A-2160121 (rs7205794) 16q23.3 CDH13, MPHOSPH6 0.24 0.01 0.01
9 SNP_A-2052542 (rs3098382) 5q13.2 MAP1B 0.24 0.04 0.19
10 SNP_A-2040586 (rs17097827) 14q32.2 BCL11B, C14orf177 0.23 0.10 0.18
11 SNP_A-8420373 (rs10186346) 2p22.1 TMEM178 0.23 0.01 0.07
12 SNP_A-1788157 (rs7158663) 14q32.2 MEG3a 0.23 0.01 0.03
13 SNP_A-4235630 (rs9641549) 7q31.2 TFEC, MDFIC 0.23 0.05 0.13
14 SNP_A-4264458 (rs1358229) 4q27 TRPC3, KIAA1109 0.23 0.01 0.00
15 SNP_A-1931666 (rs6707698) 2q34 IKZF2, ERBB4 0.22 0.03 0.02
a Known imprinted gene
Table 3. Top 15 ASM sites in cortex (BA9), ASM score averaged across individuals.
Rank SNP ID Location Associated gene(s) BA9 ASM score Cerebellum ASM score Blood ASM score
1 SNP_A-8625237 (rs12493005) 3q26.32 TBL1XR1 0.24 0.24 0.20
2 SNP_A-8463467 (rs17164474) 7q35 OR2F2, OR2F1 0.23 0.17 0.17
3 SNP_A-1841543 (rs10234308) 7p15.3 MGC87042 0.23 0.25 0.23
4 SNP_A-8652129 (rs2479084) 1p36.21 FHAD1 0.22 0.13 0.18
5 SNP_A-8301602 (rs398225) 3p25.3 SRGAP3, RAD18 0.21 0.18 0.21
6 SNP_A-2107106 (rs987377) 6q21 AIM1a, ATG5 0.20 0.16 0.15
7 SNP_A-2052542 (rs3098382) 5q13.2 MAP1B 0.19 0.24 0.04
8 SNP_A-2307481 (rs716591) 15q26.2 LOC400456, MCTP2 0.19 0.21 0.17
9 SNP_A-8643280 (rs3121125) 1q21.1 HFE2, NBPF10 0.19 0.17 0.15
10 SNP_A-8326632 (rs1542180) 2q31.1 HOXD3, HOXD4 0.19 0.24 0.21
11 SNP_A-1998023 (rs9722212) 9q34.11 TOR1B, PTGES 0.19 0.15 0.19
12 SNP_A-8640607 (rs12632177) 3q27.1 MCF2L2 0.18 0.11 0.07
13 SNP_A-4291638 (rs12670584) 7p13 YKT6 0.18 0.19 0.01
14 SNP_A-1892234 (rs17303015) 5p12 MGC42105 0.18 0.11 0.03
15 SNP_A-8653671 (rs4871852) 8p21.3 TNFRSF10D 0.18 0.09 0.11
a Known imprinted gene
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correlated for loci characterized by high ASM scores. For
probes informative in at least 2 individuals we examined the
range of ASM scores across individuals and identiﬁed the top
ranked variable ASM probes in each tissue (Table S5-S7) as
well as cross-tissue variable sites, which show consistent inter-
individual variation across all tissues (Table 6). Some sites
show evidence of allelic-ﬂipping in ASM score between individ-
uals, indicative of genomic imprinting. These included several
probes in the vicinity of the imprinted gene cluster on chromo-
some 15q11.2 (Figs. 4A-C). High ASM scores were also
observed in the vicinity of other known imprinted loci, for
example, SNRPN (Fig. S8A), DLGAP2 (Fig. S8B), AIM1
(Fig. S8C), MEG3 (Fig. S8D), BLCAP (Fig. S8E), and GRB10
(Fig. S8F), in addition to loci suspected to be imprinted, e.g.,
TRAPPC9 (Fig. S8G), EVX1 (Fig. S8H), and TGFBI/VTRNA2
(Fig. S8I); however, we were unable to examine variable ASM
in many of these regions because they were only informative
(i.e., heterozygous) in a single individual. Notably, we also iden-
tiﬁed allelic-ﬂipping in the vicinity of loci not previously char-
acterized as being imprinted, for example WRB (Fig. 4D) and
ITPKI (Fig. S9). Other variable ASM sites are marked by both
high and low ASM scores in different individuals, rather than
allelic-ﬂipping between them, for example,MGST3/LOC400794
(Table S5). Interestingly, we identiﬁed a number of sites charac-
terized by tissue-speciﬁc variable ASM. A notable example is
the imprinted gene GRB10, which has been previously shown
to be differentially maternally- and paternally-expressed in a
tissue-speciﬁc manner29,33 (Fig. S8F).
Variable ASM sites are ﬂanked by extended regions of
intermediate DNA methylation
We next quantiﬁed genome-wide patterns of DNA methyla-
tion in a larger sample (nD39) of matched whole blood,
cortex (BA9), and cerebellum samples using the Illumina
Inﬁnium HumanMethylation450 BeadChip (450K array).
For the 100 top-ranked ASM sites in each of the 3 tissues,
plus the 100 top-ranked cross-tissue, tissue-speciﬁc, and
variable ASM sites we identiﬁed probes on the array located
within 1 kb of the ASM marker SNPs (Table S8; detailed in
Table S9–S17) to investigate patterns of DNA methylation
across an extended region. As expected, regions around
known imprinted loci identiﬁed by our ASM analysis are
ﬂanked by extended regions of intermediate DNA methyla-
tion (i.e., average levels of DNA methylation between 0.4
and 0.6) (Fig. 5A and Fig. 5B). We observe a highly signiﬁ-
cant enrichment (P range D 6.82 £ 10¡11 – 0.005) of inter-
mediate DNA methylation relative to overall levels
identiﬁed on the 450K array in regions ﬂanking variable
ASM sites in all 3 tissues (Table 7 and Fig. 6). For example,
intermediate DNA methylation was observed around the
variable ASM site overlapping WRB (Fig. 5C), that showed
evidence of allelic-ﬂipping (Fig. 4D). Another probe exhibit-
ing variable ASM annotated to TGFBI/VTRNA2-1 on chro-
mosome 5 also shows a similar pattern of intermediate
DNA methylation (Fig. 5D). Interestingly, 4 individuals are
distinguished by consistent hypomethylation in whole blood
and cortex across 16 of the 19 sites, consistent with previ-
ous reports describing polymorphic imprinting of this
locus.39,40
Identiﬁcation of tissue-speciﬁc genotype-driven ASM
In contrast to the intermediate DNA methylation patterns
enriched in the vicinity of variable ASM sites, non-variable
ASM (i.e., characterized by consistent ASM scores across indi-
viduals) is not signiﬁcantly enriched for intermediate DNA
methylation and in some cases is exempliﬁed by trimodal pat-
terns of DNA methylation, which are highly suggestive of geno-
type-driven ASM acting in cis. Of note, we also observe
examples of tissue-speciﬁc genotype-driven ASM. For example,
a tissue-speciﬁc ASM site identiﬁed as showing allelically-
skewed DNA methylation in cerebellum (ASM score D 0.16)
Figure 1. Allelic-skewing is less prevalent and less variable across cortical regions
compared to cerebellum and whole blood. (A) The average proportion of informa-
tive amplicons showing an ASM score  0.10 for the 6 cortical regions proﬁled as
well as averaged across the cortical areas (Ctx) is consistently lower (ASM score
rangeD 0.34–0.61%) than in cerebellum (Cer) (ASM prevalenceD 1.14%) or blood
(ASM prevalence D 0.84%). Standard errors are shown for tissues for which sam-
ples were available from all 3 individuals. (B) – (E) Correlations of ASM scores are
shown with each point representing one probe in one individual. Probes classiﬁed
as allelically-skewed at an ASM score  0.10 in only one of the 2 compared tissues
are highlighted in red. A higher degree of between-tissue variability is observed
between cerebellum, cortex, and whole blood than between different cortical
regions (shown as an example is BA8 vs. BA10). This difference becomes even
more pronounced when restricting the set of probes to those that show allelic-
skewing at an ASM score  0.10 in at least one of the 2 compared tissues (see sub-
set correlation r’).
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but not whole blood (ASM score D 0.03) or cortex (ASM score
D 0.04) (Fig. 7A) located in an intron of the gene SYNJ2 is
ﬂanked by trimodal levels of DNA methylation in cerebellum
but not blood or cortex (Fig. 7B).
Discussion
This study conﬁrms the relatively widespread distribution of
allelically-skewed DNA methylation in the human genome,
corroborating our previous data generated in whole blood.7 We
also present evidence for tissue-speciﬁc differences in the quan-
tity and distribution of ASM between different regions of the
human brain, and between brain and whole blood. Our ﬁnd-
ings are in line with previous reports, conﬁrming the impor-
tance of tissue-speciﬁc DNA methylation proﬁles across the
brain.22,41
Although our data conﬁrm previous studies, identifying
more between-tissue variation than inter-individual variation,28
we ﬁnd clear examples where ASM is variable between individ-
uals. While the number of samples proﬁled in this study is too
small to accurately determine how much of the observed inter-
individual variation in ASM results from genetic and non-
genetic effects, previous studies suggest that the majority of
such variation is likely to be genetically driven.7,8,11 Interest-
ingly, we identify instances of tissue-speciﬁc allelically-skewed
DNA methylation resulting from both genomic imprinting and
genotypic effects. For example, we observe tissue-speciﬁc vari-
able ASM around the imprinted growth factor receptor-bound
protein 10 gene (GRB10), which encodes a protein that inter-
acts with insulin-like growth factors42,43 and we observe geno-
type-driven ASM exclusively in cerebellum for several probes
within the synaptojanin 2 gene (SYNJ2), which encodes a pro-
tein involved in the uncoating of vesicles.44,45 Such tissue-spe-
ciﬁc ASM has important implications for epigenetic
epidemiology, and provides a mechanism by which genotype
may exert an effect on gene function and regulation in a tissue-
speciﬁc manner.
This study has a number of important limitations. First,
although we used a unique set of samples comprising of
matched tissues obtained from the same donors, the number of
individuals proﬁled in our analysis was small, meaning we can-
not deﬁnitively distinguish between genetic and non-genetic
effects, or make broad statements about general patterns of
inter-individual variation of ASM. Our Illumina 450K array
validation studies were undertaken in a larger set of individuals,
but could only conﬁrm intermediate levels of DNA methylation
and not detect allele-speciﬁc patterns. Second, given the limited
availability of RNA from the same samples, we were unable to
relate our ASM ﬁndings to allelic patterns of gene expression in
the same individuals. Previous studies, however, have shown
that ASM is linked to allele-speciﬁc expression of nearby
genes.28 Third, our analyses were undertaken on whole tissue,
Figure 2. Multiple loci are characterized by consistent allelic-skewing of DNA methylation across all tissues. Heatmaps display allele signal intensities for genomic DNA
(G), MSRE-digested DNA (D) and fully unmethylated, MSRE-digested DNA (U) in all tissues. A and B denote the 2 alleles of the SNP and brightness represents the quantile
normalized signal intensity, with the scale displayed below the heatmap. Shown are the 2 top-ranked probes characterized by consistent ASM across tissues. These two
probes were informative in (A) individual 2 for rs10234308 and (B) individual 3 for rs12493005.
Table 4. Top 15 loci characterized by consistent ASM across cerebellum, whole blood, and cortex (BA9).
Rank SNP ID Location
Associated
gene(s)
Cerebellum
ASM score
Blood
ASM score
BA9
ASM score Tissue average
1 SNP_A-1841543 (rs10234308) 7p15.3 MGC87042 0.25 0.23 0.23 0.24
2 SNP_A-8625237 (rs12493005) 3q26.32 TBL1XR1 0.24 0.20 0.24 0.22
3 SNP_A-8326632 (rs1542180) 2q31.1 HOXD3, HOXD4 0.24 0.21 0.19 0.21
4 SNP_A-8301602 (rs398225) 3p25.3 SRGAP3, RAD18 0.18 0.21 0.21 0.20
5 SNP_A-8463467 (rs17164474) 7q35 OR2F2, OR2F1 0.17 0.17 0.23 0.19
6 SNP_A-2307481 (rs716591) 15q26.2 MCTP2, LOC400456 0.21 0.17 0.19 0.19
7 SNP_A-1894705 (rs986324) Xp22.11 DDX53, ZNF645 0.18 0.20 0.17 0.18
8 SNP_A-2071005 (rs4687210) 3q28 UTS2D 0.16 0.22 0.17 0.18
9 SNP_A-1998023 (rs9722212) 9q34.11 PTGES, TOR1B 0.15 0.19 0.19 0.18
10 SNP_A-8652129 (rs2479084) 1p36.21 FHAD1 0.13 0.18 0.22 0.18
11 SNP_A-8696273 (rs1003533) 5q31.1 C5orf56 0.29 0.16 0.07 0.17
12 SNP_A-1862496 (rs17578280) 1p31.1 LRRIQ3, NEGR1 0.18 0.17 0.17 0.17
13 SNP_A-2040586 (rs17097827) 14q32.2 C14orf177, BCL11B 0.23 0.10 0.18 0.17
14 SNP_A-1932077 (rs220030) 15q11.2 SNRPNa 0.18 0.18 0.15 0.17
15 SNP_A-2107106 (rs987377) 6q21 AIM1a, ATG5 0.16 0.15 0.20 0.17
a Known imprinted gene
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and represent aggregate values across a number of individual
cell types. Fourth, the MSNP approach utilizes SNP microar-
rays—these do not interrogate the whole genome, and can only
assess pools of DNA molecules. Allelic patterns of DNA meth-
ylation across individual DNA molecules cannot be directly
assessed using this approach, as would be possible using
Table 5. Top 15 tissue-speciﬁc ASM sites, deﬁned by highly variable ASM scores across cerebellum, whole blood, and cortex (BA9).
Rank SNP ID Location Associated gene (s) Cerebellum ASM score Blood ASM score BA9 ASM score SD
1 SNP_A-4255628 (rs959246) 18q12.3 SLC14A2, SETBP1 ¡0.30 ¡0.03 ¡0.05 0.15
2 SNP_A-1946136 (rs927000) 20q13.12 STK4 ¡0.04 0.23 0.01 0.15
3 SNP_A-8438077 (rs585451) 15q21.2 ATP8B4, DTWD1 0.01 ¡0.25 0.00 0.15
4 SNP_A-8397727 (rs1123514) 5q13.3 ENC1, RGNEF ¡0.16 0.11 ¡0.01 0.13
5 SNP_A-2273834 (rs2252267) 14q23.1 PRKCH 0.19 ¡0.03 ¡0.05 0.13
6 SNP_A-4264458 (rs1358229) 4q27 TRPC3, KIAA1109 ¡0.23 0.01 0.00 0.13
7 SNP_A-8643616 (rs11700515) 21q22.3 COL6A1, PCBP3 0.20 ¡0.01 ¡0.03 0.13
8 SNP_A-2180729 (rs10276966) 7p15.2 HIBADH, EVX1b ¡0.01 ¡0.25 ¡0.03 0.13
9 SNP_A-4210659 (rs10517764) 4q32.2 NAF1, FSTL5 0.07 ¡0.14 ¡0.15 0.13
10 SNP_A-1997061 (rs10512149) 9q21.33 SLC28A3, NTRK2 ¡0.19 0.02 0.05 0.13
11 SNP_A-2160121 (rs7205794) 16q23.3 CDH13, MPHOSPH6 ¡0.24 ¡0.01 ¡0.01 0.13
12 SNP_A-8667432 (rs519782) 1p36.11 C1orf201 0.19 ¡0.04 ¡0.01 0.13
13 SNP_A-1787058 (rs10951911) 7p12.3 TNS3, C7orf65 ¡0.20 ¡0.01 0.04 0.13
14 SNP_A-1931666 (rs6707698) 2q34 IKZF2, ERBB4 ¡0.22 ¡0.03 0.02 0.13
15 SNP_A-8502638 (rs10989120) 9q31.1 TMEFF1, C9orf30 0.04 ¡0.20 ¡0.15 0.13
b Suspected imprinted gene
Figure 3. A number of loci are characterized by allelic-skewing of DNA methylation in only one tissue with minimal ASM present in any of the other tissues examined.
Heatmaps display allele signal intensities for genomic DNA (G), MSRE-digested DNA (D) and fully unmethylated, MSRE-digested DNA (U) in all tissues. A and B denote the
2 alleles of the SNP and brightness represents the quantile normalized signal intensity, with the scale displayed below the heatmap. Two of the top-ranked cerebellum-
speciﬁc ASM signals are (A) rs959246 (informative for individual 3) and (B) rs2252267 (informative for individual 2). The tissue-speciﬁc patterns of DNA methylation in
these 2 loci were validated by clonal bisulﬁte sequencing, conﬁrming the ﬁndings from the MSNP assay (C,D). Each row represents a single DNA molecule, with black
dots depicting methylated cytosines and white dots depicting unmethylated cytosines. The percentage of methylated cytosines for each sample is displayed below the
plots. The amplicon spanning the DMR associated with rs959246 in (C) did not encompass a SNP enabling us to distinguish between the 2 alleles, however the methyla-
tion pattern shows evidence for tissue-speciﬁc intermediate methylation (IM) in the cerebellum. G and A in (D) denote the 2 alleles determined by SNP variation within
the amplicon in heterozygous individual 2. Cerebellum-speciﬁc hypomethylation of the A allele is observed surrounding rs2252267, with individual 3 (homozygous for
the G allele) being highly methylated in all 3 tissues.
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bisulﬁte-sequencing methods. Furthermore, our threshold for
calling allelic imbalances in DNA methylation is somewhat
arbitrary; it is likely that our data is confounded by both false
positives and negatives. We did, however, ﬁnd very consistent
overlap in whole blood ASM data with that reported in our pre-
vious study using the same laboratory and analysis methods,7
conﬁrming the validity of the MSNP approach. Furthermore,
we validated our ﬁndings using 2 independent platforms: clonal
bisulﬁte sequencing and the Illumina 450K Human methyla-
tion array. Using the latter, we were able to show that variable
ASM sites are located in an extended context of intermediate
DNA methylation, supporting a regional regulatory role of
DNA methylation in these domains, which is potentially driv-
ing intermediate expression levels in a quantitative manner
Table 6. Top 15 variable ASM sites, deﬁned by average range of ASM scores between individuals across cerebellum, whole blood, and cortex (BA9).
Rank SNP ID Location Associated gene(s) Cerebellum range Blood range BA9 range Average range
1 SNP_A-8579417 (rs1538116) 1q24.1 MGST3, LOC400794 0.24 0.35 0.32 0.30
2 SNP_A-2019421 (rs2244352) 21q22.2 WRB 0.36 0.24 0.29 0.30
3 SNP_A-4219174 (rs2346019) 5q31.1 TGFBI, VTRNA2b 0.23 0.23 0.30 0.25
4 SNP_A-4208914 (rs927651) 20q13.2 CYP24A1 0.25 0.23 0.17 0.22
5 SNP_A-8717059 (rs12713666) 2p13.3 ARHGAP25 0.26 0.15 0.21 0.21
6 SNP_A-8692937 (rs4605656) 4q24 CXXC4, TACR3 0.16 0.18 0.25 0.20
7 SNP_A-8634251 (rs1209228) 14q24.2 RGS6, SIPA1L1 0.19 0.15 0.24 0.19
8 SNP_A-8329713 (rs16825906) 3q13.31 LSAMP, IGSF11, LOC285194 0.21 0.13 0.22 0.19
9 SNP_A-8713358 (rs16890883) 4p15.33 CPEB2, LOC152742 0.24 0.14 0.17 0.19
10 SNP_A-8638348 (rs4525744) 2p21 SRBD1 0.20 0.18 0.17 0.18
11 SNP_A-1855770 (rs3764124) 13q34 CUL4A 0.16 0.23 0.15 0.18
12 SNP_A-4259064 (rs7766133) 6p22.3 MBOAT1 0.17 0.17 0.20 0.18
13 SNP_A-2118217 (rs1695824) 1p36.33 VWA1, TMEM88B 0.25 0.16 0.13 0.18
14 SNP_A-1880775 (rs6116750) 20p12.3 PROKR2 0.23 0.13 0.18 0.18
15 SNP_A-8424056 (rs3922835) 18q12.1 CDH2b, CHST9 0.18 0.04 0.32 0.18
b Suspected imprinted gene
Figure 4. Cases of allelic-ﬂipping of DNA methylation between individuals are found both in known imprinted gene clusters as well as regions not previously
conﬁrmed as being imprinted. The heatmaps show allele signal intensities for genomic DNA (G), MSRE-digested DNA (D) and fully unmethylated, MSRE-digested DNA (U)
in all tissues. A and B denote the 2 alleles of the SNP and brightness represents the quantile normalized signal intensity, with the scale displayed below the heatmap. (A)-
(C) Three probes in the vicinity of the known imprinted cluster on chromosome 15q11.2 show variable ASM and allelic-ﬂipping in cerebellum [(A) rs940596, (B)
rs11633486, (C) rs11854691]. (D) Allelic-ﬂipping of DNA methylation across all tissues is observed in the vicinity of WRB (rs2244352), which has not been reported as
imprinted previously.
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across gene regulation clusters.12 In addition, we observed a sig-
niﬁcant enrichment of ASM in regions characterized by DHS
peaks across several tissues. This enrichment of ASM in the
vicinity of markers of open chromatin supports the involve-
ment of ASM in transcriptional activity.
To conclude, we explored inter- and intra-individual varia-
tion in ASM across several regions of the human brain and
whole blood frommultiple individuals. Consistent with previous
studies, we ﬁnd relatively widespread ASM, observing allelically-
skewed DNA methylation ﬂanking known imprinted regions,
and show that ASM sites are often located in an extended geno-
mic context of intermediate DNAmethylation. Interestingly, we
detect cases of genotype-driven ASM, which are also tissue-spe-
ciﬁc. These ﬁndings contribute to our understanding about the
nature of differential DNA methylation across tissues and have
important implications for genetic studies of complex disease.
As a resource to the community, ASM patterns across each of
the tissues studied are available in a searchable online database:
http://epigenetics.essex.ac.uk/ASMBrainBlood.
Materials and methods
Genome-wide analysis of allelically-skewed DNA
methylation
Post-mortem brain and pre-mortem whole blood samples from 2
female and one male donors were provided by the MRC London
Figure 5. Regions around variable ASM sites are enriched for genomic domains characterized by intermediate DNA methylation. Flanking regions (1 kb) of variable ASM
sites show a signiﬁcant enrichment in intermediately methylated probes on the Illumina 450K Human Methylation Array (P range D 6.82 £ 10¡11 – 0.005). The scatter
plots (A)-(D) show the location of genes and imprinting control regions (ICR) if overlapping the plotting window, as well as the location of the SNP from the MSNP assay
(gray vertical line). These intermediate DNA methylation patterns span several known imprinted regions, for example (A) a ﬂanking region of rs220030 in the SNRPN
imprinted DMR, and (B) a region around rs2735971 in the imprinted gene H19. (C) Other sites showing allelic-ﬂipping and intermediately methylated ﬂanking regions lie
in areas not previously known to be imprinted, for example rs2244352, which lies in an intron of WRB. (D) A polymorphic ASM pattern is observed in a ﬂanking region
around rs2346019, a downstream gene variant of VTRNA2-1, in which the majority of samples display intermediate DNA methylation in cortex (BA9) and whole blood. Of
note, 4 samples show consistent hypomethylation across this region.
Table 7. Enrichment in intermediate methylation (IM) near ASM regions.
IM rate O/E P
Bloodd 5.88% 0.98 0.576
Cerebellumd 11.49% 1.75 0.059
BA9d 13.29% 1.45 0.065
Cross-tissue 8.11% 0.87 0.741
Tissue-speciﬁc 8.00% 0.85 0.701
Variable 38.46% 4.10 9.56 £ 10¡11
Variable (BA9)d 37.50% 4.09 8.86 £ 10¡9
Variable (cerebellum)d 16.95% 2.58 0.005
Variable (blood)d 34.48% 5.77 6.82 £ 10¡11
c IM is deﬁned as an average methylation between 0.4 and 0.6, enrichment P val-
ues are based on a hypergeometric test based on the background distribution of
IM.
d We used tissue-speciﬁc background distributions for ASM types based on single
tissues.
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Neurodegenerative Disease Brain Bank (http://www.kcl.ac.uk/
ioppn/depts/bcn/Our-research/Neurodegeneration/brain-bank.
aspx). Subjects were approached in life for written consent for
brain banking, and all tissue donations were collected and stored
following legal and ethical guidelines (NHS reference number 08/
MRE09/38; the HTA license number for the LBBND brain bank
is 12293). All samples were free from neuropathological and neu-
ropsychiatric disease. A detailed list of brain regions obtained for
each individual is provided in Table S18. Genomic DNA was iso-
lated from all tissue samples using a standard phenol-chloroform
protocol and assessed for purity and degradation prior to analysis
(see Davies et al.22 for additional information about the samples
used in this study). The MSNP method, described previously,6,7
was used to quantitatively assess allelic-skewing of DNAmethyla-
tion across the genome. Brieﬂy, Affymetrix Genome-wide
Human SNP 6.0 Arrays were used to genotype a) DNA from
each tissue sample digested with a cocktail of MSREs (HpaII:
50 -C^ C G G-30, HhaI: 50 -G C G^ C-30, and AciI: 50 -C^C G C-30)
(D arrays), b) unmethylated whole-genome-ampliﬁed DNA for
each individual digested with the same cocktail of MSREs to con-
trol for possible confounding effects of DNA sequence polymor-
phisms located at MSRE cut-sites (U arrays), and c) genomic
DNA from each of the 3 individuals to identify heterozygous
(informative) SNPs (G arrays). Unmethylated DNA was
produced by whole-genome amplifying 100 ng cerebellum DNA
using the Qiagen RepliG kit (Qiagen, Crawley, UK) using the
manufacturer’s protocol. In total 28 genotyping arrays were proc-
essed: 22 D arrays (DNA from between 6 and 7 brain regions plus
whole blood, for each individual), 3 U arrays (one for each indi-
vidual), and 3 G arrays (one for each individual). Additional
methodological details are available in Schalkwyk et al.7
Selection of informative SNPs and quantiﬁcation of ASM
To be informative in the ASM assay, SNPs must be heterozy-
gous, and the amplicon must contain an MSRE cut site.6,7 To
guard against poorly performing SNP probes we also removed
consistently low signal intensity SNPs across the 22 G arrays,
and those yielding a highly variable U/G signal ratio
(SD > 0.077) across all samples. A total of 220,449 SNPs passed
our stringent ﬁltering criteria and were classiﬁed as informative
and heterozygous in at least one individual. The number of
informative SNPs in each of the individual samples proﬁled by
theMSNPmethod is shown in Table S19. Quantitative measures
of ASM were derived by comparing signal intensities between
the D (MSRE digested) and G (genomic DNA) arrays using the
SNPMaP package (v1.02) in R that was developed for the esti-
mation of allele frequencies in DNA pools genotyped on SNP
Figure 6. Regions around variable ASM are enriched in intermediate DNA methylation. The distributions of DNA methylation at the 65 Illumina 450K Human Methylation
Array probes within 1 kb of the top 100 variable ASM sites (Table S14) show an enrichment in intermediately methylated probes compared to DNA methylation levels
across the whole array (shown in gray) in (A) cortex (BA9), (B) cerebellum, and (C) whole blood).
Figure 7. Genotype-driven ASM can be tissue-speciﬁc. (A) The tissue-speciﬁc ASM site rs1009014, located in an intron of SYNJ2, shows allelic-skewing of DNA methylation
in cerebellum (ASM score D 0.16) but not in cortex (ASM score D 0.04) or whole blood (ASM score D 0.03). (B) DNA methylation levels for Illumina 450K Human Methyla-
tion Array probes in cerebellum across a ﬂanking region of this locus exhibit a genotype-driven tissue-speciﬁc DNA methylation pattern. The scatter plot shows the loca-
tion of SYNJ2 (transcript variant 1), as well as the location of the informative SNP from the MSNP assay (gray vertical line).
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arrays.46 Brieﬂy, relative allele score (RAS) values were gener-
ated for all SNPs on the array, which are deﬁned as A/(A C B),
where A and B are the intensities of the probes for the 2 alleles of
a given SNP. For a given SNP in a heterozygous individual, ASM
(or allelic-skewing of DNA methylation) is detected as a differ-
ence in RAS between the G and D arrays. We call this difference
in RAS “ASM score” and deﬁne probes showing an absolute
ASM score  0.10 as “allelically-skewed.” A UCSC custom
annotation track showing the location of all 220,449 loci and the
degree of allelic-skewing in DNA methylation across each tissue
and individual is available for download from our website
(http://epigenetics.essex.ac.uk/ASMBrainBlood). Enrichment
analyses were performed using a Kruskal-Wallis rank-sum test
for ASM rank differences between the annotated genic regions.
This non-parametric method tests whether multiple samples
were drawn from the same distribution and is the multivariate
extension of the better-known Wilcoxon rank-sum test. This
test allowed us to avoid selecting a speciﬁc threshold for ASM
scores and does not assume a normal distribution of residuals.
Of the 220,449 informative probes, 219,921 could be annotated
to speciﬁc deﬁned genic regions. Annotations were based on
the Homo sapiens hg19 build from UCSC using the Annota-
tionHub Bioconductor package47 classifying probes as residing
in introns (n D 100,254), 50UTRs (n D 347), 30UTRs (n D
2,341), coding regions (n D 2,569), intergenic regions (n D
110,186) and promoters (n D 4,224). A Nemenyi test for pair-
wise multiple comparisons of mean rank sums as implemented
in the PMCMR R package48 was used for post-hoc compari-
sons. ENCODE tracks for DHS peaks in frontal cortex, frontal
cerebrum, cerebellum, CD14C monocytes, na€ıve B cells, H1
human embryonic stem cells (H1-hesc), heart, and ﬁbroblasts
were obtained from the UCSC genome browser (http://hgdown
load.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeO
penChromDnase/). For the DHS enrichment analyses we tested
whether the rank-sums for ASM scores differed signiﬁcantly in
informative probes deﬁned by the presence or absence of DHS
peaks using a Wilcoxon rank-sum test. Informative probes
were ranked according to ASM scores with higher absolute
ASM scores corresponding to lower ranks.
Clonal bisulﬁte sequencing
Two regions were subsequently selected for clonal bisulﬁte
sequencing analysis to further verify our ﬁndings and deter-
mine the precise allele-speciﬁc patterns of DNA methylation.
Following sodium bisulﬁte treatment and bisulﬁte-PCR ampli-
ﬁcation, amplicons were cloned using the TOPO TA cloning
method (Invitrogen, Paisley, UK) and sequenced with BigDye
v1.1 sequencing chemistry (Applied Biosystems) (Table S20).
Sequencing traces were visualized, quality controlled, and
aligned using BiQ Analyzer.49 All data were tested for complete
sodium bisulﬁte conversion, with an overall conversion rate
> 99.9% estimated by BiQ Analyzer.
Validation of ASM on the llumina 450K HumanMethylation
microarray
Further analysis of ASM sites was undertaken on a larger col-
lection of post-mortem brain samples (n D 34), comprising
BA9, BA21, BA28/34, and cerebellum, which were also free of
any neuropathology and neuropsychiatric disease. Additionally
we analyzed matched pre-mortem whole blood samples, which
were available for a subset (n D 8), as well as 5 unmatched
blood samples (see Table S18). The 3 individuals proﬁled by
MSNP were included in this analysis. DNA (500 ng) from each
sample was treated with sodium bisulﬁte in duplicate, using the
EZ-96 DNA methylation kit (Zymo Research, CA, USA). DNA
methylation was quantiﬁed using the Illumina Inﬁnium
HumanMethylation450 BeadChip (Illumina Inc., CA, USA)
run on an Illumina HiScan System (Illumina) using the manu-
facturers’ standard protocol, with pre-processing and stringent
quality control performed as previously described.50 We used
the GenomicRanges package51 to extract data for all CpG sites
within 1 kb of candidate ASM SNPs and examined patterns of
DNA methylation across the 3 tissues. Intermediate DNA
methylation was deﬁned as an average methylation value
between 0.4 and 0.6 across all individuals. To test for statistical
signiﬁcance of enrichment in intermediately methylated probes
we used a hypergeometric distribution based on the number of
probes tested and the background of intermediately methylated
probes across the whole array. Annotation of genes in the
methylation plots (Fig. 5 and Fig. 7B) was obtained from the
UCSC Genome Browser hg19 assembly. Imprinting control
region (ICR) annotation was obtained from the web resource
on human DMRs provided by the Department of Medical and
Molecular Genetics, Kings College London (https://atlas.genet
ics.kcl.ac.uk) and lifted over from hg18 to hg19.
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